Clincosm LogoSign in Get a demo

Stage IIIA Non-Small Cell Lung Cancer

Showing 26 - 50 of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of the Lung, Recurrent NSCLC, Stage IA NSCLC Trial in Nashville (acetylsalicylic acid, laboratory biomarker

Terminated
  • Adenocarcinoma of the Lung
  • +7 more
  • acetylsalicylic acid
  • laboratory biomarker analysis
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jan 10, 2020

Extensive Stage Small Cell Lung Cancer, Healthy, no Evidence of Disease, Limited Stage Small Cell Lung Cancer Trial in Madison

Completed
  • Extensive Stage Small Cell Lung Cancer
  • +11 more
  • exercise intervention
  • +3 more
  • Madison, Wisconsin
  • +1 more
Nov 14, 2019

Caregiver, Psychological Impact of Cancer and Its Treatment, Recurrent NSCLC Trial in United States (Palliative Therapy,

Completed
  • Caregiver
  • +7 more
  • Palliative Therapy
  • +2 more
  • Duarte, California
  • +4 more
May 6, 2019

B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)

Completed
Has Results
  • B-Cell Neoplasm
  • +15 more
  • Stanford, California
    Stanford University Medical Center
Dec 11, 2018

NSCLC, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Guangzhou (drug, device, other)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • +4 more
  • vitamin C
  • +2 more
  • Guangzhou, China
    Clifford Hospital
Nov 29, 2018

Limited Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer, Stage IA NSCLC Trial in Winston-Salem (other, procedure,

Completed
  • Limited Stage Small Cell Lung Cancer
  • +8 more
  • questionnaire administration
  • +6 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 30, 2018

Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in United States (Azacitidine, Docetaxel,

Terminated
Has Results
  • Recurrent Non-Small Cell Lung Carcinoma
  • +3 more
  • Los Angeles, California
  • +4 more
Jun 29, 2018

Metastatic Tumor, Recurrent Tumor, Recurrent Non-Small Cell Lung Carcinoma Trial in Winston-Salem (Laboratory Biomarker

Terminated
  • Metastatic Neoplasm
  • +6 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jun 29, 2018

Recurrent NSCLC, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in United States (3-dimensional conformal radiation therapy,

Completed
Has Results
  • Recurrent Non-small Cell Lung Cancer
  • +2 more
  • 3-dimensional conformal radiation therapy
  • +3 more
  • Scottsdale, Arizona
  • +142 more
Nov 2, 2017

Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial in

Terminated
Has Results
  • Stage IA Non-Small Cell Lung Carcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Oct 30, 2017

Stage IIIA NSCLC Trial in Philadelphia (drug, procedure, radiation)

Withdrawn
  • Stage IIIA Non-Small Cell Lung Cancer
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Oct 19, 2017

Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Seattle (vorinostat, paclitaxel, radiation therapy)

Terminated
Has Results
  • Stage IIIA Non-small Cell Lung Cancer
  • Stage IIIB Non-small Cell Lung Cancer
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 16, 2017

Stage IIIA NSCLC Trial in United States (Neoadjuvant Cisplatin, nab-paclitaxel, Adjuvant Cisplatin,nab-paclitaxel, Adjuvant

Terminated
Has Results
  • Stage IIIA Non-Small Cell Lung Cancer
  • Neoadjuvant Cisplatin, nab-paclitaxel
  • +2 more
  • Tampa, Florida
  • +8 more
Mar 29, 2017

Estrogen Receptor Negative, Head and Neck Squamous Cell Carcinoma, HER2/Neu Negative Trial (Laboratory Biomarker Analysis,

Withdrawn
  • Estrogen Receptor Negative
  • +22 more
  • Laboratory Biomarker Analysis
  • +2 more
  • (no location specified)
Apr 20, 2017

Cachexia, Fatigue, Pulmonary Complications Trial (behavioral, procedure, other)

Withdrawn
  • Cachexia
  • +7 more
  • exercise intervention
  • +3 more
  • (no location specified)
Apr 12, 2017

Adenocarcinoma of the Lung, Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum Trial in Philadelphia

Completed
  • Adenocarcinoma of the Lung
  • +25 more
  • educational intervention
  • medical chart review
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Apr 5, 2017

Recurrent Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial

Completed
Has Results
  • Recurrent Non-Small Cell Lung Carcinoma
  • +5 more
  • Baltimore, Maryland
  • +1 more
Jan 27, 2017

Stage IIIA NSCLC Trial in Seoul (Pembrolizumab, Curative resection, Neoadjuvant concurrent chemoradiotherapy)

Unknown status
  • Stage IIIA Non-small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Department of Medicine, Samsung Medical Center, Sungkyunkwan Uni
Feb 14, 2017

Recurrent NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Richmond (diffusion-weighted magnetic resonance imaging,

Withdrawn
  • Recurrent Non-small Cell Lung Cancer
  • +4 more
  • diffusion-weighted magnetic resonance imaging
  • +3 more
  • Richmond, Virginia
    Virginia Commonwealth University Massey Cancer Center
Dec 15, 2016

Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial in

Terminated
  • Stage IA Non-Small Cell Lung Carcinoma
  • +4 more
  • Lexington, Kentucky
  • +2 more
Nov 17, 2016

Recurrent NSCLC, Stage IIB NSCLC, Stage IIIA NSCLC Trial in Seattle (3-dimensional conformal radiation therapy,

Terminated
  • Recurrent Non-small Cell Lung Cancer
  • +3 more
  • 3-dimensional conformal radiation therapy
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 3, 2015

Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Canada, United States (Erlotinib

Terminated
Has Results
  • Recurrent Non-Small Cell Lung Carcinoma
  • +3 more
  • Erlotinib Hydrochloride
  • Pemetrexed Disodium
  • Scottsdale, Arizona
  • +268 more
Oct 6, 2015

HIV Infection, Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC Trial in Los Angeles, San Diego, Bronx (Erlotinib

Terminated
  • HIV Infection
  • +4 more
  • Erlotinib Hydrochloride
  • +3 more
  • Los Angeles, California
  • +4 more
Oct 5, 2015

Stage IIIA NSCLC, Stage IIIB NSCLC, Stage IV NSCLC Trial in United States (Paclitaxel, Carboplatin, Vorinostat)

Terminated
Has Results
  • Stage IIIA Non-Small Cell Lung Cancer
  • +2 more
  • Duarte, California
  • +14 more
Jul 22, 2015

Adult Solid Tumor, Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC Trial in Buffalo (Buparlisib, Cisplatin,

Withdrawn
  • Adult Solid Neoplasm
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 11, 2015